Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Control of oncogene expression by antisense nucleic acids

Identifieur interne : 001652 ( Istex/Corpus ); précédent : 001651; suivant : 001653

Control of oncogene expression by antisense nucleic acids

Auteurs : C. Hélène

Source :

RBID : ISTEX:A30033E18DF3274809DD5C3D846A3F55724A019A

English descriptors


Url:
DOI: 10.1016/0959-8049(93)E0352-Q

Links to Exploration step

ISTEX:A30033E18DF3274809DD5C3D846A3F55724A019A

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Control of oncogene expression by antisense nucleic acids</title>
<author>
<name sortKey="Helene, C" sort="Helene, C" uniqKey="Helene C" first="C." last="Hélène">C. Hélène</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A30033E18DF3274809DD5C3D846A3F55724A019A</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1016/0959-8049(93)E0352-Q</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001652</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001652</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Control of oncogene expression by antisense nucleic acids</title>
<author>
<name sortKey="Helene, C" sort="Helene, C" uniqKey="Helene C" first="C." last="Hélène">C. Hélène</name>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">European Journal of Cancer</title>
<title level="j" type="abbrev">EJC</title>
<idno type="ISSN">0959-8049</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1994">1994</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1721">1721</biblScope>
<biblScope unit="page" to="1726">1726</biblScope>
</imprint>
<idno type="ISSN">0959-8049</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-8049</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Acad</term>
<term>Adjuvant tamoxifen</term>
<term>Animal models</term>
<term>Animal studies</term>
<term>Antigene</term>
<term>Antigene oligonucleotides</term>
<term>Antigene strategy</term>
<term>Antisense</term>
<term>Antisense inhibition</term>
<term>Antisense oligonucleotide</term>
<term>Antisense oligonucleotides</term>
<term>Antisense research</term>
<term>Base pairs</term>
<term>Biol chem</term>
<term>Biological effects</term>
<term>Biological response</term>
<term>Block translation</term>
<term>Breast cancer</term>
<term>Breast cancer patients</term>
<term>Cell culture experiments</term>
<term>Cell cultures</term>
<term>Cell proliferation</term>
<term>Cellular uptake</term>
<term>Circular oligonucleotides</term>
<term>Cleavage</term>
<term>Clinical trials</term>
<term>Complementary sequence</term>
<term>Control gene expression</term>
<term>Double helix</term>
<term>Early breast cancer</term>
<term>Endometrial cancer</term>
<term>Form hoogsteen</term>
<term>Gene</term>
<term>Gene expression</term>
<term>Gene promoter</term>
<term>Helene</term>
<term>Helix</term>
<term>Hoogsteen</term>
<term>Hoogsteen hydrogen bonds</term>
<term>Human bladder carcinoma</term>
<term>Immune response</term>
<term>Intercalating agents</term>
<term>Large number</term>
<term>Major groove</term>
<term>Malignant cells</term>
<term>Mrna</term>
<term>Mutation</term>
<term>Nanoparticles</term>
<term>Nat1</term>
<term>Nucl acids</term>
<term>Nucleic</term>
<term>Nucleic acid</term>
<term>Nucleic acids</term>
<term>Nude mice</term>
<term>Oligonucleotide</term>
<term>Oligonucleotide decoy</term>
<term>Oligonucleotides</term>
<term>Oligopurine sequence</term>
<term>Oncogene</term>
<term>Oncogene expression</term>
<term>Oncogene family</term>
<term>Original tumour</term>
<term>Polyalkylcyanoacrylate nanoparticles</term>
<term>Proc</term>
<term>Proc nat1 acad</term>
<term>Proc nat1 acadsci</term>
<term>Reactive group</term>
<term>Repair genes</term>
<term>Ribozyme</term>
<term>Short oligonucleotides</term>
<term>Synthetic antisense oligonucleotides</term>
<term>Tamoxifen</term>
<term>Target sequence</term>
<term>Therapeutical applications</term>
<term>Transcription</term>
<term>Transcription factor</term>
<term>Transcription factors</term>
<term>Transgenic mice</term>
<term>Translation machinery</term>
<term>Triple helix</term>
<term>Triple helix formation</term>
<term>Tumour</term>
<term>Tumour cells</term>
<term>Tumour development</term>
<term>Tumour growth</term>
<term>Viral</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<istex>
<corpusName>elsevier</corpusName>
<keywords>
<teeft>
<json:string>antisense</json:string>
<json:string>oligonucleotides</json:string>
<json:string>oligonucleotide</json:string>
<json:string>tumour</json:string>
<json:string>helix</json:string>
<json:string>mrna</json:string>
<json:string>oncogene</json:string>
<json:string>antisense oligonucleotides</json:string>
<json:string>antigene</json:string>
<json:string>ribozyme</json:string>
<json:string>triple helix formation</json:string>
<json:string>nat1</json:string>
<json:string>antisense oligonucleotide</json:string>
<json:string>nanoparticles</json:string>
<json:string>proc</json:string>
<json:string>helene</json:string>
<json:string>tamoxifen</json:string>
<json:string>acad</json:string>
<json:string>viral</json:string>
<json:string>mutation</json:string>
<json:string>hoogsteen</json:string>
<json:string>antigene oligonucleotides</json:string>
<json:string>gene expression</json:string>
<json:string>double helix</json:string>
<json:string>nude mice</json:string>
<json:string>proc nat1 acad</json:string>
<json:string>base pairs</json:string>
<json:string>nucleic</json:string>
<json:string>target sequence</json:string>
<json:string>endometrial cancer</json:string>
<json:string>triple helix</json:string>
<json:string>cell cultures</json:string>
<json:string>biological response</json:string>
<json:string>nucleic acids</json:string>
<json:string>transcription</json:string>
<json:string>transcription factor</json:string>
<json:string>large number</json:string>
<json:string>major groove</json:string>
<json:string>control gene expression</json:string>
<json:string>oncogene expression</json:string>
<json:string>hoogsteen hydrogen bonds</json:string>
<json:string>clinical trials</json:string>
<json:string>block translation</json:string>
<json:string>cleavage</json:string>
<json:string>gene</json:string>
<json:string>reactive group</json:string>
<json:string>antigene strategy</json:string>
<json:string>tumour development</json:string>
<json:string>nucleic acid</json:string>
<json:string>human bladder carcinoma</json:string>
<json:string>cell culture experiments</json:string>
<json:string>antisense inhibition</json:string>
<json:string>oligonucleotide decoy</json:string>
<json:string>repair genes</json:string>
<json:string>polyalkylcyanoacrylate nanoparticles</json:string>
<json:string>animal studies</json:string>
<json:string>biological effects</json:string>
<json:string>tumour growth</json:string>
<json:string>animal models</json:string>
<json:string>therapeutical applications</json:string>
<json:string>cellular uptake</json:string>
<json:string>breast cancer</json:string>
<json:string>short oligonucleotides</json:string>
<json:string>transcription factors</json:string>
<json:string>transgenic mice</json:string>
<json:string>adjuvant tamoxifen</json:string>
<json:string>early breast cancer</json:string>
<json:string>oligopurine sequence</json:string>
<json:string>form hoogsteen</json:string>
<json:string>intercalating agents</json:string>
<json:string>gene promoter</json:string>
<json:string>circular oligonucleotides</json:string>
<json:string>cell proliferation</json:string>
<json:string>immune response</json:string>
<json:string>original tumour</json:string>
<json:string>tumour cells</json:string>
<json:string>synthetic antisense oligonucleotides</json:string>
<json:string>breast cancer patients</json:string>
<json:string>antisense research</json:string>
<json:string>malignant cells</json:string>
<json:string>complementary sequence</json:string>
<json:string>translation machinery</json:string>
<json:string>nucl acids</json:string>
<json:string>biol chem</json:string>
<json:string>proc nat1 acadsci</json:string>
<json:string>oncogene family</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>C. Hélène</name>
</json:item>
</author>
<arkIstex>ark:/67375/6H6-F8G587XS-8</arkIstex>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>Full-length article</json:string>
</originalGenre>
<qualityIndicators>
<score>6.377</score>
<pdfWordCount>4365</pdfWordCount>
<pdfCharCount>29286</pdfCharCount>
<pdfVersion>1.2</pdfVersion>
<pdfPageCount>6</pdfPageCount>
<pdfPageSize>648 x 878 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractWordCount>1</abstractWordCount>
<abstractCharCount>0</abstractCharCount>
<keywordCount>0</keywordCount>
</qualityIndicators>
<title>Control of oncogene expression by antisense nucleic acids</title>
<pmid>
<json:string>7833151</json:string>
</pmid>
<pii>
<json:string>0959-8049(93)E0352-Q</json:string>
</pii>
<genre>
<json:string>research-article</json:string>
</genre>
<serie>
<title>in press</title>
<language>
<json:string>unknown</json:string>
</language>
</serie>
<host>
<title>European Journal of Cancer</title>
<language>
<json:string>unknown</json:string>
</language>
<publicationDate>1994</publicationDate>
<issn>
<json:string>0959-8049</json:string>
</issn>
<pii>
<json:string>S0959-8049(00)X0195-5</json:string>
</pii>
<volume>30</volume>
<issue>11</issue>
<pages>
<first>1721</first>
<last>1726</last>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
</host>
<namedEntities>
<unitex>
<date>
<json:string>1994</json:string>
</date>
<geogName></geogName>
<orgName>
<json:string>Antisense Research and Applications, CRS</json:string>
<json:string>Jordan VC</json:string>
</orgName>
<orgName_funder></orgName_funder>
<orgName_provider></orgName_provider>
<persName>
<json:string>M. Thuona</json:string>
<json:string>G. Garovoy</json:string>
<json:string>M. Ablation</json:string>
<json:string>Tam S. Hunt</json:string>
<json:string>Inhibition</json:string>
<json:string>A. Inhibition</json:string>
<json:string>J. Treatment</json:string>
</persName>
<placeName></placeName>
<ref_url></ref_url>
<ref_bibl>
<json:string>[4]</json:string>
<json:string>[34]</json:string>
<json:string>[18]</json:string>
<json:string>[6]</json:string>
<json:string>[22]</json:string>
<json:string>[8]</json:string>
<json:string>[21]</json:string>
<json:string>[27]</json:string>
<json:string>[3]</json:string>
<json:string>[20]</json:string>
<json:string>[5]</json:string>
<json:string>[26]</json:string>
<json:string>[25]</json:string>
<json:string>[2]</json:string>
<json:string>[24]</json:string>
</ref_bibl>
<bibl></bibl>
</unitex>
</namedEntities>
<ark>
<json:string>ark:/67375/6H6-F8G587XS-8</json:string>
</ark>
<categories>
<wos>
<json:string>1 - science</json:string>
<json:string>2 - oncology</json:string>
</wos>
<scienceMetrix>
<json:string>1 - health sciences</json:string>
<json:string>2 - clinical medicine</json:string>
<json:string>3 - oncology & carcinogenesis</json:string>
</scienceMetrix>
<scopus>
<json:string>1 - Life Sciences</json:string>
<json:string>2 - Biochemistry, Genetics and Molecular Biology</json:string>
<json:string>3 - Cancer Research</json:string>
<json:string>1 - Health Sciences</json:string>
<json:string>2 - Medicine</json:string>
<json:string>3 - Oncology</json:string>
</scopus>
</categories>
<publicationDate>1994</publicationDate>
<copyrightDate>1994</copyrightDate>
<doi>
<json:string>10.1016/0959-8049(93)E0352-Q</json:string>
</doi>
<id>A30033E18DF3274809DD5C3D846A3F55724A019A</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/fulltext.pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/bundle.zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/fulltext.tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a">Control of oncogene expression by antisense nucleic acids</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher scheme="https://scientific-publisher.data.istex.fr">ELSEVIER</publisher>
<availability>
<licence>
<p>elsevier</p>
</licence>
</availability>
<p scheme="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M"></p>
<date>1994</date>
</publicationStmt>
<notesStmt>
<note type="research-article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</note>
<note type="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note>
<note>This paper is based on a plenary lecture presented at the 7th European Congress on Clinical Oncology (ECC07) in Jerusalem on 14–18 November 1993.</note>
<note type="content">Section title: Feature article</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a">Control of oncogene expression by antisense nucleic acids</title>
<author xml:id="author-0000">
<persName>
<forename type="first">C.</forename>
<surname>Hélène</surname>
</persName>
</author>
<idno type="istex">A30033E18DF3274809DD5C3D846A3F55724A019A</idno>
<idno type="ark">ark:/67375/6H6-F8G587XS-8</idno>
<idno type="DOI">10.1016/0959-8049(93)E0352-Q</idno>
<idno type="PII">0959-8049(93)E0352-Q</idno>
</analytic>
<monogr>
<title level="j">European Journal of Cancer</title>
<title level="j" type="abbrev">EJC</title>
<idno type="pISSN">0959-8049</idno>
<idno type="PII">S0959-8049(00)X0195-5</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1994"></date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1721">1721</biblScope>
<biblScope unit="page" to="1726">1726</biblScope>
</imprint>
</monogr>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>1994</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
<revisionDesc>
<change when="1994">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/fulltext.txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Elsevier, elements deleted: tail">
<istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration>
<istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType>
<istex:document>
<converted-article version="4.5.2" docsubtype="fla">
<item-info>
<jid>EJC</jid>
<aid>93E0352Q</aid>
<ce:pii>0959-8049(93)E0352-Q</ce:pii>
<ce:doi>10.1016/0959-8049(93)E0352-Q</ce:doi>
<ce:copyright type="unknown" year="1994"></ce:copyright>
</item-info>
<head>
<ce:article-footnote>
<ce:label></ce:label>
<ce:note-para>This paper is based on a plenary lecture presented at the 7th European Congress on Clinical Oncology (ECC07) in Jerusalem on 14–18 November 1993.</ce:note-para>
</ce:article-footnote>
<ce:dochead>
<ce:textfn>Feature article</ce:textfn>
</ce:dochead>
<ce:title>Control of oncogene expression by antisense nucleic acids</ce:title>
<ce:author-group>
<ce:author>
<ce:given-name>C.</ce:given-name>
<ce:surname>Hélène</ce:surname>
<ce:cross-ref refid="COR1">
<ce:sup></ce:sup>
</ce:cross-ref>
</ce:author>
<ce:correspondence id="COR1">
<ce:label></ce:label>
<ce:text>Correspondence to C. Helene at the Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM U. 201-CNRS URA 481, 43 rue Cuvier, 75231 Paris Cedex 05 and Rhone-Poulenc, 25 Quai Paul Doumer, 92408 Coubevoie Cedex, France.</ce:text>
</ce:correspondence>
</ce:author-group>
<ce:date-received day="11" month="8" year="1994"></ce:date-received>
<ce:date-accepted day="31" month="8" year="1994"></ce:date-accepted>
</head>
</converted-article>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo>
<title>Control of oncogene expression by antisense nucleic acids</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA">
<title>Control of oncogene expression by antisense nucleic acids</title>
</titleInfo>
<name type="personal">
<namePart type="given">C.</namePart>
<namePart type="family">Hélène</namePart>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="research-article" displayLabel="Full-length article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-1JC4F85T-7">research-article</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1994</dateIssued>
<copyrightDate encoding="w3cdtf">1994</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
</language>
<note>This paper is based on a plenary lecture presented at the 7th European Congress on Clinical Oncology (ECC07) in Jerusalem on 14–18 November 1993.</note>
<note type="content">Section title: Feature article</note>
<relatedItem type="host">
<titleInfo>
<title>European Journal of Cancer</title>
</titleInfo>
<titleInfo type="abbreviated">
<title>EJC</title>
</titleInfo>
<genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre>
<originInfo>
<publisher>ELSEVIER</publisher>
<dateIssued encoding="w3cdtf">1994</dateIssued>
</originInfo>
<identifier type="ISSN">0959-8049</identifier>
<identifier type="PII">S0959-8049(00)X0195-5</identifier>
<part>
<date>1994</date>
<detail type="volume">
<number>30</number>
<caption>vol.</caption>
</detail>
<detail type="issue">
<number>11</number>
<caption>no.</caption>
</detail>
<extent unit="issue-pages">
<start>1597</start>
<end>1736</end>
</extent>
<extent unit="pages">
<start>1721</start>
<end>1726</end>
</extent>
</part>
</relatedItem>
<identifier type="istex">A30033E18DF3274809DD5C3D846A3F55724A019A</identifier>
<identifier type="ark">ark:/67375/6H6-F8G587XS-8</identifier>
<identifier type="DOI">10.1016/0959-8049(93)E0352-Q</identifier>
<identifier type="PII">0959-8049(93)E0352-Q</identifier>
<recordInfo>
<recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-HKKZVM7B-M">elsevier</recordContentSource>
</recordInfo>
</mods>
<json:item>
<extension>json</extension>
<original>false</original>
<mimetype>application/json</mimetype>
<uri>https://api.istex.fr/ark:/67375/6H6-F8G587XS-8/record.json</uri>
</json:item>
</metadata>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001652 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001652 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:A30033E18DF3274809DD5C3D846A3F55724A019A
   |texte=   Control of oncogene expression by antisense nucleic acids
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021